Europe Compression Therapy Market is expected to reach US$ 829.6 Million by 2034

According to The Insight Partners' research, the Europe Compression Therapy Market was valued at US$ 571.3 Million in 2025 and is expected to reach US$ 829.6 Million by 2034, registering a CAGR of 4.3% from 2026 to 2034.

Government-driven coverage & reimbursement expansion and decentralized & home-based care adoption are among the critical factors driving the European compression therapy market.

An important opportunity for compression therapy in Europe stems from the continued expansion of reimbursement for evidence-based compression products through national healthcare systems and updated clinical guidelines. Across many European countries, medically prescribed compression stockings, bandages, and related products are already reimbursed for conditions such as chronic venous disease, venous leg ulcers, and lymphedema. Recent implementation of the EU Medical Device Regulation (EU MDR) has also strengthened confidence in the safety and clinical performance of medical devices, encouraging broader adoption of high-quality compression products. Furthermore, increasing emphasis on value-based healthcare and reducing preventable hospitalizations has prompted several health systems to expand access to compression therapy as a cost-effective intervention. As reimbursement policies continue to support evidence-based treatment and health technology assessments recognize the long-term economic benefits of preventing chronic complications, manufacturers have greater opportunities to introduce innovative compression technologies and improve patient access across European markets.

On the contrary, the complex regulatory approval and product compliance requirements hamper the growth of the Europe compression therapy market.

Europe Compression Therapy Market Segmentation Analysis:

• By Product, the Europe Compression Therapy Market is segmented into Compression Bandages, Compression Wraps, Compression Stockings, Compression Sleeves, Compression Tape, Compression Braces, Compression Pumps, and Others. The Compression Bandages segment is projected to expand at a CAGR of 4.9% during 2026 - 2034.
• By Technology, the Europe Compression Therapy Market is segmented into Static Compression Therapy and Dynamic Compression Therapy. The Static Compression Therapy segment is projected to expand at a CAGR of 4.2% during 2026 - 2034.
• By Application, the Europe Compression Therapy Market is segmented into Lymphedema, Leg Ulcer, Deep Vein Thrombosis, Varicose veins, Lipedema, and Others. The Varicose veins segment is projected to expand at a CAGR of 4.4% during 2026 - 2034.
• By End User, the Europe Compression Therapy Market is segmented into Hospitals and Clinics, Nursing Care Centers, Home Care Settings, and Others. The Hospitals and Clinics segment is projected to expand at a CAGR of 4.7% during 2026 - 2034.

By country, the Europe Compression Therapy Market is categorized into Germany, the United Kingdom, France, Italy, Spain, and the Rest of Europe. Germany is projected to expand at a CAGR of 4.7% during 2026 - 2034.

Key players operating in the Compression Therapy Market are Arjo AB, Essity AB, Lohmann & Rauscher GmbH & Co KG, Paul Hartmann AG, Convatec Inc, Enovis Corp, Solventum Corporation, Juzo, SIGVARIS GROUP, and medi Canada Inc, among others.

• In Sep 2025, L&R completed the acquisition of a 49% stake in the ADA Group. The strategic cooperation between L&R and ADA represents an important step in L&R's European market presence, its growth activities, and the resulting increased ability to ensure the supply of gauze and nonwoven products. The partnership also strengthens Europe's processing industry.
• In March 2025, Lohmann & Rauscher Group (L&R) acquired Unisurge International Ltd., the UK's market-leading and renowned manufacturer and supplier of Custom Procedure Packs (CPTs), disposable surgical products, surgical instruments, and further OR products. With this acquisition, the L&R Group - a leading, internationally active private company in medical devices and services - secures market access to the hospital sector and surgical products in the UK. Unisurge will remain an independent company within the L&R Group. The British sales subsidiary of the group, L&R Medical UK Ltd, will also not be involved in the OR business.